Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
Dose-dense chemotherapy is a chemotherapy treatment plan in which drugs are given with less
time between treatments than in standard chemotherapy. The two chemotherapy drugs used in
this study, docetaxel and cisplatin, are approved for the treatment of lung cancer when given
every 21 days. This study is exploring the response to chemotherapy when these drugs are
given every 14 days. In addition, genetic tests will be performed on pre-treatment specimens
to identify signatures that may predict chemotherapy sensitivity or resistance.